Joyce Y Wu1, Jurriaan M Peters2, Monisha Goyal3, Darcy Krueger4, Mustafa Sahin2, Hope Northrup5, Kit Sing Au5, Gary Cutter3, E Martina Bebin6. 1. Division of Pediatric Neurology, Mattel Children's Hospital at UCLA, Los Angeles, California. 2. Department of Neurology, Boston Children's Hospital, Boston, Massachusetts. 3. Department of Neurology, University of Alabama Birmingham, Birmingham, Alabama. 4. Cincinnati Children's Hospital, Cincinnati, Ohio. 5. University of Texas Houston, Houston, Texas. 6. Department of Neurology, University of Alabama Birmingham, Birmingham, Alabama. Electronic address: ebebin@uab.edu.
Abstract
BACKGROUND: We assessed the clinical utility of routine electroencephalography (EEG) in the prediction of epilepsy onset in asymptomatic infants with tuberous sclerosis complex. METHODS: This multicenter prospective observational study recruited infants younger than 7 months, seizure-free and on no antiepileptic drugs at enrollment, who all underwent serial physical examinations and video EEGs throughout the study. Parental education on seizure recognition was completed at the time of initial enrollment. Once seizure onset occurred, standard of care was applied, and subjects were followed up until 24 months. RESULTS: Forty patients were enrolled, 28 older than 12 months with completed EEG evaluation at the time of this interim analysis. Of those, 19 (67.8%) developed seizures. Epileptic spasms occurred in 10 (52.6%), focal seizures in five (26.3%), generalized tonic-clonic seizure in one (5.3%), and a combination of epileptic spasms and focal seizures in three (15.7%). Fourteen infants (73.6%) had the first emergence of epileptiform abnormalities on EEG at an average age 4.2 months, preceding seizure onset by a median of 1.9 months. Hypsarrhythmia or modified hypsarrhythmia was not found in any infant before onset of epileptic spasms. All children with epileptiform discharges subsequently developed epilepsy (100% positive predictive value), and the negative predictive value for not developing epilepsy after a normal EEG was 64%. CONCLUSIONS: Serial routine EEGs in infants with tuberous sclerosis complex is a feasible strategy to identify individuals at high risk for epilepsy. The most frequent clinical presentation was epileptic spasms followed by focal seizures, and then a combination of both seizure types.
BACKGROUND: We assessed the clinical utility of routine electroencephalography (EEG) in the prediction of epilepsy onset in asymptomatic infants with tuberous sclerosis complex. METHODS: This multicenter prospective observational study recruited infants younger than 7 months, seizure-free and on no antiepileptic drugs at enrollment, who all underwent serial physical examinations and video EEGs throughout the study. Parental education on seizure recognition was completed at the time of initial enrollment. Once seizure onset occurred, standard of care was applied, and subjects were followed up until 24 months. RESULTS: Forty patients were enrolled, 28 older than 12 months with completed EEG evaluation at the time of this interim analysis. Of those, 19 (67.8%) developed seizures. Epileptic spasms occurred in 10 (52.6%), focal seizures in five (26.3%), generalized tonic-clonic seizure in one (5.3%), and a combination of epileptic spasms and focal seizures in three (15.7%). Fourteen infants (73.6%) had the first emergence of epileptiform abnormalities on EEG at an average age 4.2 months, preceding seizure onset by a median of 1.9 months. Hypsarrhythmia or modified hypsarrhythmia was not found in any infant before onset of epileptic spasms. All children with epileptiform discharges subsequently developed epilepsy (100% positive predictive value), and the negative predictive value for not developing epilepsy after a normal EEG was 64%. CONCLUSIONS: Serial routine EEGs in infants with tuberous sclerosis complex is a feasible strategy to identify individuals at high risk for epilepsy. The most frequent clinical presentation was epileptic spasms followed by focal seizures, and then a combination of both seizure types.
Authors: D Domańska-Pakieła; M Kaczorowska; E Jurkiewicz; K Kotulska; D Dunin-Wąsowicz; S Jóźwiak Journal: Eur J Paediatr Neurol Date: 2013-12-31 Impact factor: 3.140
Authors: Marian E Williams; Deborah A Pearson; Jamie K Capal; Anna W Byars; Donna S Murray; Robin Kissinger; Sarah E O'Kelley; Ellen Hanson; Nicole M Bing; Bridget Kent; Joyce Y Wu; Hope Northrup; E Martina Bebin; Mustafa Sahin; Darcy Krueger Journal: Am Psychol Date: 2019-04
Authors: Aristea S Galanopoulou; Michael Wong; Devin Binder; Adam L Hartman; Elizabeth M Powell; Avtar Roopra; Richard Staba; Annamaria Vezzani; Brandy Fureman; Ray Dingledine Journal: Epilepsy Curr Date: 2016 May-Jun Impact factor: 7.500
Authors: Abigail Dickinson; Kandice J Varcin; Mustafa Sahin; Charles A Nelson; Shafali S Jeste Journal: Autism Res Date: 2019-08-16 Impact factor: 5.216
Authors: Mustafa Sahin; Elizabeth P Henske; Brendan D Manning; Kevin C Ess; John J Bissler; Eric Klann; David J Kwiatkowski; Steven L Roberds; Alcino J Silva; Coryse St Hillaire-Clarke; Lisa R Young; Mark Zervas; Laura A Mamounas Journal: Pediatr Neurol Date: 2016-04-02 Impact factor: 3.372
Authors: Peter E Davis; Rajna Filip-Dhima; Georgios Sideridis; Jurriaan M Peters; Kit Sing Au; Hope Northrup; E Martina Bebin; Joyce Y Wu; Darcy Krueger; Mustafa Sahin Journal: Pediatrics Date: 2017-11-03 Impact factor: 7.124